21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Antigen-specific, tolerance-inducing microparticles and uses thereof
#1802Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult
#1803BACTERICIDAL MONOCLONAL ANTIBODY TARGETING KLEBSIELLA PNEUMONIAE
#1804Tetrandrine family pharmaceutical formulations and method
#1805Salt of EGFR inhibitor, crystalline form and uses thereof
#1806AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
#1807Ferroportin inhibitors
#1808Compounds and compositions as protein kinase inhibitors
#1809Compounds and compositions as protein kinase inhibitors
#1810Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
#1811Compositions and methods for treating cancers
#1812Compositions and methods for the treatment of fatty acid metabolism disorders
#1813ARTICLES COMPRISING NANO-MATERIALS FOR GEOMETRY-GUIDED STEM CELL DIFFERENTIATION AND ENHANCED BONE GROWTH
#1814PHARMACEUTICAL FORMULATION FOR REDUCING BLADDER SPASMS AND METHOD OF USE THEREOF
#1815TREATMENT OF EPITHELIAL LAYER LESIONS
#1816SDF-1 FOR ANAL AND SPHINCTER WOUND HEALING
#1817Peptides and method for treatment of cardiac arrest
#1818Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors
#1819Composition for the prevention and/or treatment of allergy symptoms
#1820Combination treatment
#1821MAPC treatment of brain injuries and diseases
#1822Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
#1823Trace element solution
#1824TREATING MALE INFERTILITY SECONDARY TO SPERM OXIDATIVE STRESS
#1825SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS
#1826Peritoneal dialysis fluid
#1827Compositions and methods for treating conditions of compromised skin barrier function
#1828Compositions of and methods of treatment with zwitterionic polysaccharide
#1829Method for treating cancer using dual antagonists of CXCR1 and CXCR2
#1830METHODS FOR TREATING INTRAPULMONARY INFECTIONS
#1831Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
#1832Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
#1833METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES
#1834Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
#1835METHOD AND COMPOSITION FOR TREATING ALZHEIMER-TYPE DEMENTIA
#1836STIMULATION OF 11B-HSD2 EXPRESSION TO IMPROVE HORMONAL THERAPY OF STEROID-DEPENDENT DISEASE
#1837PTGDR-1 AND/OR PTGDR-2 ANTAGONISTS FOR PREVENTING AND/OR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS
#1838Method for treating paroxysmal nocturnal hemoglobinuria
#1839Sacubitril calcium salts
#1840Amino acid compositions and methods for the treatment of liver diseases
#1841BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS
#1842Treatment of prostate carcinoma
#1843Microvesicles derived from nucleated, mammalian cells and use thereof
#1844Methods for diagnosis of tuberculosis
#1845USP30 INHIBITORS AND METHODS OF USE
#1846IgG stimulated remyelination of peripheral nerves
#1847Use of IL-15 to increase thymic output and to treat lymphopenia
#1848Beta-lactamase inhibitors
#1849NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#1850METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES
#1851Quinoxalinyl-piperazinamide methods of use
#1852Isothiocyanate functional surfactant and associated method of use
#1853Remineralisation of calcified tissue
#1854REMINERALISATION OF CALCIFIED TISSUE
#1855Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke
#1856Controlled drug release from electrospun fibers
#1857Sustained release eye drop formulations
#1858Anti-PD-L1-anti-TIM-3 bispecific antibodies
#1859Method for improving the efficacy of a survivin vaccine in the treatment of cancer
#1860Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant
#1861COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION
#1862Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
#1863Compositions and methods for invasive and non-invasive procedural skincare
#1864Composition containing herbal medicine extracts of Pinellia and Scutellaria for reducing side effects due to anticancer drugs
#1865Herbal supplements and methods of use thereof
#1866Combination Therapy for Treating Proliferative Diseases
#1867ENHANCED IMMUNE RESPONSE IN CATTLE UPON TREATMENT WITH NITRIC OXIDE
#1868ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND
#1869COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS
#1870COMBINATION THERAPY FOR TREATMENT OF HUMAN NEURODEGENERATIVE DISEASES
#1871VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#1872COMPOSITION
#1873Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
#1874COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY
#1875Low dose oral dipyridamole compositions and uses thereof
#1876Methods for inducing apoptosis in cancer cells
#1877Azetidine derivative, preparation method therefor, and use thereof
#1878COMPOUNDS AND METHODS TARGETING GPER IN CANCER
#1879COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#1880Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
#1881Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
#1882Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
#1883COMPOSITIONS AND METHODS TO TREAT URINARY TRACT INFECTIONS
#1884Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases
#1885LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND A NON-FATTY ACID ANTI-INFLAMMATORY AGENT
#1886Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1887Dosage forms and therapeutic uses of L-4-chlorokynurenine
#1888Solid-forming local anesthetic formulations for pain control
#1889Composition and method for treating skin conditions
#1890Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#1891Nanoparticles, composition and system for delivering 5FU and uses thereof
#1892Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
#1893GLUCOPYRANOSIDE COMPOUND
#1894Tricyclic fused derivatives of 1-(cyclo)alkyl pyridin-2-one useful for the treatment of cancer
#18957-Oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections (changed by PCT to: 7-OXO -6-(SULFOOXY)- 1,6-DIAZABICYCLO [3.2.1] OCTANE CONTAINING COMPOUNDS AND THEIR USE IN TREATMENT OF BACTERIAL INFECTIONS
#1896RORC2 INHIBITORS AND METHODS OF USE THEREOF
#1897IMMUNOREGULATORY AGENTS
#1898Continudihydroxyphenyl Neurotransmitter Compounds, Compositions And Methods
#1899Polynucleotides encoding humanized anti-CD40 antibodies
#1900Aluminum based adjuvants for tolerogenic vaccination
#1901Pharmaceutical formulations for the oral delivery of peptide drugs
#1902DIAGNOSTIC BIOMARKERS FOR FIBROTIC DISORDERS
#1903Compositions and Methods for Pain Relief
#1904Process to enhance the bioactivity of ashwagandha extracts
#1905USE OF FLAXSEED AND FLAXSEED DERIVATIVES FOR TREATMENT OF NEUROLOGICAL DISORDERS AND VIRAL DISEASES
#1906Formulation for targeting cancer in humans and canines
#1907Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
#1908METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE
#1909Method of treating bacterial infections
#1910Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
#1911NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#1912USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK)
#1913METHODS AND COMPOSITIONS FOR TREATMENT OF METASTATIC AND REFRACTORY CANCERS AND TUMORS
#1914SYK INHIBITORS
#1915Combination of opioids and anticancer drugs for cancer treatment
#1916Trilobine and its natural analogs for use as a drug
#1917Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
#1918PHARMACEUTICAL COMPOSITIONS
#1919PHARMACEUTICAL COMPOSITIONS OF SODIUM PICOSULFATE, MAGNESIUM OXIDE AND CITRIC ACID
#1920Combinations of isomers of dihydrotetrabenazine
#1921Uses of combinations (+)-α-dihydrotetrabenazine and (−)-α-dihydrotetrabenazine in methods of treating movement disorder
#1922Methods of treatment for cholestatic and fibrotic diseases
#1923Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
#1924TOPICAL SILIBININ FORMULATIONS AND USES THEREFOR
#1925MEDICAMENT FOR PREVENTING OR INHIBITING ACUTE KIDNEY INJURY
#1926Histone deacetylase inhibitors for the use in the treatment of drug resistant melanoma
#1927METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL
#1928No-rinse chemical foam containing trifarotene, and use thereof in the treatment of acne
#1929IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS
#1930Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
#1931Short non-coding protein regulatory RNAs (sprRNAs) and methods of use
#1932Combination therapy for treatment of disease
#19337-dehydrocholesterol derivatives and methods using same
#1934Compositions for preventing and/or treating degenerative disorders of the central nervous system
#1935Anti-cancer and anti-inflammatory therapeutics and methods thereof
#1936Treatment of high Trop-2 expressing triple negative breast cancer (TNBC) with sacituzumab govitecan (IMMU-132) overcomes homologous recombination repair (HRR) rescue mediated by Rad51
#1937Drug device configured for wireless communication
#1938Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response
#1939METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#1940SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
#1941Combined preparations for the treatment of cancer or infection
#1942Method for improving gingivitis and periodontitis by antibacterial, antioxidant and anti-inflammatory effects and inhibition of alveolar bone loss of complex extracts of moringa leaf and eucommia bark
#1943Methods for treatment of diarrhea
#1944Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease
#1945LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE
#1946Combination therapy for cancer
#1947TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS
#1948Stabilized modified release vitamin D formulation and method of administering same
#1949Stabilized modified release vitamin D formulation and method of administering same
#1950Pharmaceutical compounds
#1951Methods of treating hepatic encephalopathy
#1952Phytoestrogen compositions and associated methods
#1953Compositions and methods of use of phorbol esters for the treatment of stroke
#1954Composition containing glibenclamide
#1955Meglumine in Combination with Another Therapeutic
#1956COMBINATION METHODS AND COMPOSITIONS
#1957Compositions and methods for treating pterygium
#1958Compositions and methods for treating hyperemia
#1959Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones
#1960Marinopyrrole derivatives and methods of making and using same
#1961FUSED PYRIMIDINE-BASED HYDROXAMATE DERIVATIVES
#1962Filter precleaner
#1963Skincare compositions
#1964Immune checkpoint inhibitor combinations
#1965Composition for prevention, alleviation or treatment of precocious puberty containing extract of coicis semen and artemisia capillaris as active ingredient
#1966Process for preparing herbal extracts
#1967Pharmaceutical wound healing composition
#1968TREATMENT AND PROPHYLAXIS OF RADIATION DERMATITIS
#1969COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS
#1970Carborane compounds and methods of use thereof
#1971Compositions and methods for treating multiple sclerosis
#1972COMPOSITION AND METHODS FOR TREATING SLEEP DISORDERS
#1973COMBINATION
#1974PHARMACEUTICAL COMPOSITION
#1975Chemoimmunotherapy for epithelial cancer
#1976Inhibitors of the plasmodial surface anion channel as antimalarials
#1977CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#1978THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
#1979MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
#1980Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
#1981COMBINATION OF RAF INHIBITORS AND AURORA KINASE INHIBITORS
#1982Composition and method for treatment of depression and psychosis in humans
#1983Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
#1984METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF MANTLE CELL LYMPHOMAS
#1985Modulators of the adenosine A3 receptors
#1986Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compounds
#1987CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#1988PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#1989TREATMENT OF SKIN CONDITIONS
#1990USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS
#1991GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS
#1992Topical dapsone and dapsone/adaplene compositions and methods for use thereof
#1993SOFT GELATIN CAPSULES CONTAINING A MIXTURE OF ANALGESICS AND DECONGESTANTS, EXPECTORANTS, ANTITUSSIVES AND/OR ANTIHISTAMINES
#1994COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
#1995NRF2 Screening Assays and Related Methods and Compositions
#1996Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
#1997Intrauterine delivery system for contraception
#1998Topical skin care formulations comprising plant extracts
#1999Inhibition and treatment of gastrointestinal biofilms
#2000Bispecific EGFR/C-Met Antibodies
#2001Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinoma
#2002D-amino acid compounds for liver disease
#2003Benzodiazepine derivatives as RSV inhibitors
#2004RAPAMYCIN ANALOGS SHOWING IMPROVED mTORC1 SPECIFICITY
#2005Bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
#2006Processes for preparing a diazabicyclooctane compound
#2007ONCOLYTIC VACCINIA VIRUS CANCER THERAPY
#2008Nucleic acid products and methods of administration thereof
#2009Anti-S100A8 for treating leukemia
#2010Composition for preventing or treating stroke or degenerative brain disease
#2011PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES
#2012USE OF A COMBINATION OF MYXOMA VIRUS AND RAPAMYCIN FOR THERAPEUTIC TREATMENT
#2013MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF
#2014Methods and compositions for the activation of gamma-delta T-cells
#2015Composition of trigofoenoside and flavonoids and methods thereof
#2016Antiviral supplement formulations
#2017METHODS FOR EXTENDING LIFESPAN AND METHODS OF SCREENING KNOWN PHARMACOLOGICAL AGENTS FOR NEW USES
#2018Vaginal inserted estradiol pharmaceutical compositions and methods
#2019Treatments for autoimmune disease
#2020Combination therapies for treatment of cancer
#2021Methods and compositions for treating drug resistance in cancer
#2022Combination therapy comprising varlitinib and an anticancer agent
#2023Compositions and methods for treating centrally mediated nausea and vomiting
#2024PHARMACEUTICAL COMBINATION COMPRISING (A) THE ALPHA-ISOFORM SPECIFIC PI3K INHIBITOR ALPELISIB (BYL719) AND (B) AN AKT INHIBITOR, PREFERABLY MK-2206, AFURESERTIB OR UPROSERTIB, AND THE USE THEREOF IN THE TREATMENT/PREVENTION OF CANCER
#2025METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS
#2026METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#2027PREPARATION AND USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS
#2028Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
#2029Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#2030COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#2031COMPOSITION FOR PREVENTING OR TREATING MITOCHONDRIAL DISEASES CAUSED BY IMMUNOSUPPRESSANTS, AND IMMUNE DISEASES, CONTAINING METFORMIN
#2032Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#2033CONTROLLED-RELEASE FORMULATIONS
#2034IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS
#2035COMPOSITIONS AND METHODS FOR TREATING CANCER VIA ANTAGONISM OF THE CD155/TIGIT PATHWAY AND TGF-BETA
#2036Indolin-2-one derivatives
#2037Process for preparing 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-N-((1S,2S)-2-hydroxycyclohexyl) benzamide or a pharmaceutically acceptable salt thereof
#2038Indolin-2-one derivatives
#2039Indolin-2-one derivatives
#2040Indolin-2-one derivatives
#2041Biomimetic hybrid gel compositions and methods of use
#2042Compositions and methods for treating cardiovascular related disorders
#2043Compositions, combinations and related methods for photoimmunotherapy
#2044Adjuvant treatment of HER2-positive breast cancer
#2045Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
#2046Compositions and methods for protecting the kidney from ischemia reperfusion injury
#2047COMBINATION THERAPY USING GLIADIN AND GAMMA AMINOBUTYRIC ACID
#2048Cyanobacterial microalgae phycocyanin and phycocyanobilin to beneficially inhibit the activity of the UDP-GDH enzyme while significantly increasing the absorption and circulation of curcumin
#2049Genetically engineered drug resistant T cells and methods of using the same
#2050COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS
#2051Trace elements
#2052Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#2053PREBIOTIC FORMULATIONS AND METHODS OF USE
#2054COMPOSITIONS AND METHODS FOR TREATING SOLID TUMORS
#2055Synergistic composition for maintenance of healthy balance of microflora
#2056Use of aminosalicylates in diarrhoea-predominent irritable bowel syndrome
#2057NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES
#2058COMBINATION OF RIBOCICLIB AND DABRAFENIB FOR TREATING OR PREVENTING CANCER
#2059Combination therapy of an HBV capsid assembly inhibitor and an interferon
#2060Use of kinase inhibitors to manage tuberculosis and other infectious diseases
#2061Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease Treatments
#2062ANTIBIOTIC GEL FORMULATION AND METHODS OF PREPARING THE ANTIBIOTIC GEL FORMULATION
#2063Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#2064Compositions for treating CMT and related disorders
#2065COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
#2066TRANSDERMAL DELIVERY OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
#2067Methods for treatment of fabry disease
#2068Antibacterial compounds
#2069Pharmaceutical antiretroviral composition
#2070MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#2071Therapeutic combinations of sesquiterpenes and flavonoids
#2072SUSTAINED RELEASE CANNABINOID FORMULATIONS
#2073METHOD FOR TREATING CANCER WITH A STAT3 PATHWAY INHIBITOR AND KINASE INHIBITOR
#2074PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES
#2075Highly stable non-vesicular nanoparticles and application thereof in treating microbial infection
#2076Topical application of dihydrotestosterone and testosterone fixed combination formulation for promoting hair growth containing formulations
#2077Topical dihydrotestosterone (DHT) for promoting hair growth-containing formulations
#2078A COMPOSITION COMPRISING PROSTACYCLIN ANDOR ANALOGUES THEREOF FOR TREATMENT OF ACUTE CRITICALLY ILL PATIENTS
#2079ASSESSING AND TREATING LYMPHOMA
#2080Immunity enhancing agent for cancer by Allergin-1 antagonist
#2081Oxabicycloheptane prodrugs
#2082ANTIVIRAL COMPOUNDS
#2083MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF
#2084Cytotoxic HEXIM1 peptides and uses thereof
#2085Liposomal compositions with light illumination-induced drug release
#2086Topical erythropoietin formulations and methods for improving wound healing with and cosmetic use of the formulations
#2087Method for producing dry extracts
#2088Synergistic antibacterial effects of magnolia bark extract and L-arginine, N--lauroyl ethyl ester on plaque biofilm
#2089Composition containing angelica extract for promoting proliferation of stem cells derived from bone marrow
#2090Bicarbonate as a potentiator for antimicrobial agents
#2091Method of treating or ameliorating skin conditions with a magnetic dipole stabilized solution
#2092Method of treating severe asthma
#2093Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#2094COMPOSITIONS COMPRISING A PI3K INHIBITOR AND AN HDAC INHIBITOR
#2095PHARMACEUTICAL COMBINATION
#2096Varlitinib for use in the treatment of resistant or refractory cancer
#2097DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#2098Compositions and methods for weight loss in at risk patient populations
#2099Pharmaceutical combination comprising the PI3K inhibitor alpelisib and the B-RAF inhibitor dabrafenib; the use of such combination in the treatment or prevention of cancer
#2100ANTIBACTERIAL COMPOSITIONS